SCHEMBL2893263

SCHEMBL2893263

CCNCCNCCNCCNCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.71
MEN1 O00255 2/20 0.71
KMT2A Q03164 2/20 0.71
GLA P06280 1/20 0.71
CYP1A2 P05177 1/20 0.67
TP53 P04637 2/20 0.58
TSHR P16473 2/20 0.56
KDM1A O60341 5/20 0.50
SAT1 P21673 3/20 0.48
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
CA12 O43570 2/20 0.38
CA6 P23280 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1543426 1.00 CYP2C19 (0.71) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL80292 0.95
Iodide SCHEMBL7119508 0.91 CYP2C19 (0.60) CYP2C19MEN1KMT2AGLACYP1A2
Hydrochloric Acid SCHEMBL13859051 0.91 CYP2C19 (0.60) CYP2C19MEN1KMT2AGLACYP1A2
Hydrochloric Acid SCHEMBL2460973 0.91
SCHEMBL11321305 0.91
SCHEMBL23739822 0.89 CYP2C19 (0.59) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL22813888 0.89 CYP2C19 (0.59) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL12085573 0.89 CYP2C19 (0.87) CYP2C19MEN1KMT2AGLACYP1A2
SCHEMBL2416226 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3568402-B1 LANTHANIDE COMPLEXES COMPRISING DERIVATIVES OF TRIETHYLENETETRAMINE-N,N,N',N'',N''',N'''-HEXAACETIC ACID UNIV ORLEANS (FR) 2022-11-02 EP disclosed
US-20210230517-A1 Use of Polypeptide NOVOZYMES A/S (DK) 2021-07-29 US disclosed
EP-3784715-A1 MODIFIED PHENALKAMINE CURING AGENT FOR EPOXY RESIN COMPOSITION AND USE THEREOF Elantas Beck India Ltd. (IN) 2021-03-03 EP disclosed
EP-3728389-A1 NEW USE OF ISOSORBIDE Elantas Europe Srl (IT) 2020-10-28 EP disclosed
US-20200056121-A1 Use of Polypeptide NOVOZYMES A/S (DK) 2020-02-20 US disclosed
US-20170081616-A1 Use of Polypeptide NOVOZYMES A/S (DK) 2017-03-23 US disclosed
US-20170081616-A1 Use of Polypeptide NOVOZYMES A/S (DK) 2017-03-23 US disclosed
US-20160220720-A1 COMPOSITIONS COMPRISING POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS PROCTER & GAMBLE (US) 2016-08-04 US disclosed
US-20160101203-A1 COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED MALODOR CONTROL POLYMERS PROCTER & GAMBLE (US) 2016-04-14 US disclosed
US-9248209-B2 Compositions comprising hydrophobically modified malodor control polymers THE PROCTER & GAMBLE COMPANY (US) 2016-02-02 US disclosed
US-20130059392-A1 AGGREGATION-INDUCED EMISSION LUMINOGENS FOR METAL ION DETECTION THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2013-03-07 US disclosed
US-20120183488-A1 COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY 2012-07-19 US disclosed
US-20120183489-A1 COMPOSITIONS COMPRISING METALLATED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY 2012-07-19 US disclosed
US-20120183488-A1 COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY 2012-07-19 US disclosed
US-20120183489-A1 COMPOSITIONS COMPRISING METALLATED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY 2012-07-19 US disclosed
WO-2012097034-A1 COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY (US) 2012-07-19 WO disclosed
WO-2012097033-A1 COMPOSITIONS COMPRISING METALLATED MALODOR CONTROL POLYMERS THE PROCTER & GAMBLE COMPANY (US) 2012-07-19 WO disclosed
WO-2012078208-A1 MALODOR CONTROL COMPOSITIONS COMPRISING MALODOR CONTROL POLYMERS AND ACID CATALYSTS AND METHODS THEREOF THE PROCTER & GAMBLE COMPANY (US) 2012-06-14 WO disclosed
US-20100286008-A1 ADDITIVE FOR OILS AND LUBRICANT CONTAINING THE SAME KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2010-11-11 US disclosed
EP-2166066-A1 ADDITIVE FOR OILS AND LUBRICANT CONTAINING THE SAME Kyowa Hakko Chemical Co., Ltd. (JP) 2010-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286008-A1 ADDITIVE FOR OILS AND LUBRICANT CONTAINING THE SAME NR0B2, NR2E1, LBR CYP2C19 3229/4885MEN1 2446/4885KMT2A 782/4885
US-20130059392-A1 AGGREGATION-INDUCED EMISSION LUMINOGENS FOR METAL ION DETECTION PARN, IK, PARG CYP2C19 3947/4885MEN1 1147/4885KMT2A 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.